ProQR Therapeutics N.V. (PRQR)
NASDAQ: PRQR · IEX Real-Time Price · USD
1.860
+0.110 (6.29%)
Jul 16, 2024, 10:32 AM EDT - Market open

ProQR Therapeutics Income Statement

Millions EUR. Fiscal year is Jan - Dec.
Year Ending
TTM Dec 31, 2023Dec 31, 2022Dec 31, 2021Dec 31, 2020Dec 31, 2019 2018 - 2013
Revenue
13.499.534.362.389.451.93
Upgrade
Revenue Growth (YoY)
252.63%118.51%83.31%-74.84%388.98%-66.45%
Upgrade
Gross Profit
13.499.534.362.389.451.93
Upgrade
Selling, General & Admin
15.6616.2418.6517.3713.6912.89
Upgrade
Research & Development
28.3725.1550.8742.2238.1446.49
Upgrade
Operating Expenses
44.0341.3869.5259.5951.8259.38
Upgrade
Operating Income
-30.55-31.86-65.16-57.21-42.37-57.45
Upgrade
Interest Expense / Income
0.431.465.133.414.031.08
Upgrade
Other Expense / Income
-4.05-5.12-5.960.010.04-2.18
Upgrade
Pretax Income
-26.92-28.2-64.33-60.62-46.44-56.35
Upgrade
Income Tax
-0.08-0.080.10.120.120.13
Upgrade
Net Income
-26.84-28.12-64.42-60.74-46.57-56.48
Upgrade
Shares Outstanding (Basic)
828172645041
Upgrade
Shares Outstanding (Diluted)
828172645041
Upgrade
Shares Change
0.84%13.08%11.62%28.21%21.99%20.51%
Upgrade
EPS (Basic)
-0.33-0.35-0.90-0.95-0.93-1.38
Upgrade
EPS (Diluted)
-0.33-0.35-0.90-0.95-0.93-1.38
Upgrade
Free Cash Flow
-32.8828.18-69.21-26.44-47-45.17
Upgrade
Free Cash Flow Per Share
-0.400.35-0.97-0.41-0.94-1.10
Upgrade
Gross Margin
100.00%100.00%100.00%100.00%100.00%100.00%
Upgrade
Operating Margin
-226.46%-334.48%-1494.82%-2405.80%-448.24%-2971.81%
Upgrade
Profit Margin
-199.02%-295.21%-1477.95%-2554.25%-492.65%-2921.88%
Upgrade
Free Cash Flow Margin
-243.79%295.82%-1587.75%-1111.73%-497.21%-2336.83%
Upgrade
EBITDA
-23.84-24.23-56.68-54.89-40.06-53.21
Upgrade
EBITDA Margin
-176.73%-254.34%-1300.30%-2308.20%-423.79%-2752.87%
Upgrade
Depreciation & Amortization
2.662.512.522.332.362.05
Upgrade
EBIT
-26.49-26.74-59.2-57.22-42.41-55.27
Upgrade
EBIT Margin
-196.42%-280.72%-1358.13%-2406.14%-448.71%-2859.03%
Upgrade
Source: Financials are provided by Nasdaq Data Link and sourced from audited reports submitted to the Securities and Exchange Commission (SEC).